IL219768A0 - Drug combination with thebromine and its use in therapy - Google Patents

Drug combination with thebromine and its use in therapy

Info

Publication number
IL219768A0
IL219768A0 IL219768A IL21976812A IL219768A0 IL 219768 A0 IL219768 A0 IL 219768A0 IL 219768 A IL219768 A IL 219768A IL 21976812 A IL21976812 A IL 21976812A IL 219768 A0 IL219768 A0 IL 219768A0
Authority
IL
Israel
Prior art keywords
thebromine
therapy
drug combination
drug
combination
Prior art date
Application number
IL219768A
Other languages
English (en)
Original Assignee
Biocopea Ltd
John Brew
Robin Mark Bannister
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41509324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL219768(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biocopea Ltd, John Brew, Robin Mark Bannister filed Critical Biocopea Ltd
Publication of IL219768A0 publication Critical patent/IL219768A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL219768A 2009-11-13 2012-05-13 Drug combination with thebromine and its use in therapy IL219768A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0919889.6A GB0919889D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
PCT/GB2010/051895 WO2011058373A2 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
IL219768A0 true IL219768A0 (en) 2012-07-31

Family

ID=41509324

Family Applications (1)

Application Number Title Priority Date Filing Date
IL219768A IL219768A0 (en) 2009-11-13 2012-05-13 Drug combination with thebromine and its use in therapy

Country Status (16)

Country Link
EP (1) EP2498777A2 (ja)
JP (2) JP2013510841A (ja)
CN (1) CN102753174A (ja)
AU (1) AU2010317667B2 (ja)
BR (1) BR112012011227A2 (ja)
CA (1) CA2780703A1 (ja)
CO (1) CO6551744A2 (ja)
GB (1) GB0919889D0 (ja)
IL (1) IL219768A0 (ja)
MX (1) MX2012005532A (ja)
NZ (1) NZ599949A (ja)
PE (1) PE20130147A1 (ja)
RU (1) RU2519086C2 (ja)
UA (1) UA108993C2 (ja)
WO (1) WO2011058373A2 (ja)
ZA (1) ZA201204248B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US20190008850A1 (en) * 2015-12-30 2019-01-10 Paul J. Markovitz Method of treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
BR9713536A (pt) * 1996-11-25 2000-11-07 Procter & Gamble Compostos heterocìclicos de guanidinila úteis como agonistas de adrenoceptores alfa-2
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6207674B1 (en) * 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
CN100579505C (zh) * 2003-05-29 2010-01-13 荷兰联合利华有限公司 头发处理组合物
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
US20080176955A1 (en) * 2007-01-16 2008-07-24 Victory Pharma, Inc. Combined administration of benzonatate and guaifenesin

Also Published As

Publication number Publication date
CA2780703A1 (en) 2011-05-19
BR112012011227A2 (pt) 2017-06-13
AU2010317667A1 (en) 2012-06-07
JP2013510841A (ja) 2013-03-28
GB0919889D0 (en) 2009-12-30
CN102753174A (zh) 2012-10-24
RU2519086C2 (ru) 2014-06-10
WO2011058373A3 (en) 2011-07-07
AU2010317667B2 (en) 2014-05-29
PE20130147A1 (es) 2013-03-13
CO6551744A2 (es) 2012-10-31
NZ599949A (en) 2013-08-30
UA108993C2 (en) 2015-07-10
JP2016128439A (ja) 2016-07-14
JP6118919B2 (ja) 2017-04-19
MX2012005532A (es) 2012-09-28
RU2012124038A (ru) 2013-12-20
EP2498777A2 (en) 2012-09-19
ZA201204248B (en) 2013-02-27
WO2011058373A2 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
IL222006A (en) Pyrulobenzodiazepine conjugates and their use in medicine
IL214244A0 (en) Scriptaid isosteres and their use in therapy
EP2579865A4 (en) COMBINATION THERAPY WITH LISDEXAMPHETAMINE AND GUANFACINE WITH EXTENDED RELEASE
HK1169997A1 (zh) 變體及其用途
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB0921803D0 (en) Drug composition and its use in therapy
IL209361A0 (en) Combination therapy with pm00104 and another antitumor agent
IL219768A0 (en) Drug combination with thebromine and its use in therapy
HK1168283A1 (zh) 類的試劑在治療抗胰島素和相關疾病的用途
GB2460178B (en) Depsipeptides and their therapeutic use
IL219769A0 (en) Drug combination with theromine and its use in therapy
GB2460181B (en) Depsipeptides and their therapeutic use
GB0921805D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
GB0905970D0 (en) Depsipeptides and their therapeutic use
HK1182397A1 (en) New octapeptide compounds and their use in therapy
GB2460180B (en) Depsipeptides and their therapeutic use
GB0920267D0 (en) Drug combination and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy
GB0909354D0 (en) Drug composition and its use in therapy
GB0918727D0 (en) Drug composition and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0909344D0 (en) Drug composition and its uses in therapy